Main
>
ONCOLOGY (**)
>
Lymphoma>NHL>B-Cell>DLBCL R/R***
>
USA. P. Brentuximab Vedotin+
>
(*) USA Approval Date: 2025. 02.12
(*) USA Approval Date: 2025. 02.12's products
This section has no products